Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors-Reference-Cited by-同舟云学术

Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors

Published:2017-06-08 Issue:6 Volume:12 Page:e0179202
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mahfouz Nadine,Tahtouh Roula,Alaaeddine Nada,El Hajj Joelle,Sarkis Riad,Hachem Ray,Raad Issam,Hilal George^ORCID

Funder

Saint Joseph University

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;J Ferlay;Int J Cancer,2010

2. Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma;C-H Hsu;Br J Cancer,2010

3. Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival;TF Paiva;BMC Cancer,2015

4. A survey of telomerase activity in human cancer;JW Shay;Eur J Cancer Oxf Engl 1990,1997

5. Telomerase activity: a biomarker of cell proliferation, not malignant transformation;CD Belair;Proc Natl Acad Sci U S A,1997

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nature’s Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization;Current Medicinal Chemistry;2024-10

2. Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-03

3. The angiogenic role of the alpha 9-nicotinic acetylcholine receptor in triple-negative breast cancers;Angiogenesis;2024-08-23

4. Recent advances in nanomaterials for the treatment of femoral head necrosis;Human Cell;2024-07-12

5. An Overview of Cancer Biology, Pathophysiological Development and It’s Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy;Cancer Investigation;2024-06-14